Table 1.
Comparisons of the demographic and clinical characteristics according to survival state at 30 days in patients with Acinetobacter baumannii bacteremia
COPD, chronic obstructive pulmonary disease; ESRD, end stage renal disease; ICU, intensive care unit; PCD, percutaneous catheter drainage; CRAB, carbapenem-resistant A. baumannii; APACHE, acute physiology and chronic health evaluation.